ECA
XYL icon

Elevated Capital Advisors’s Xylem XYL Stock Holding History

Elevated Capital Advisors’s Portfolio XYL Stock Details XYL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$473 Hold
4
– – ﹤0.01% 800
2026
Q1 		$478 Hold
4
– – ﹤0.01% 790
2025
Q4 		$545 Buy
+4
New +$575 ﹤0.01% 758

Other funds holding XYL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Elevated Capital Advisors's XYL Position: Q2 2026 in Review

Elevated Capital Advisors held its Xylem (XYL) position steady in Q2 2026 at 4 shares worth $473. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Elevated Capital Advisors first reported a position in XYL in Q4 2025 and has held it in 3 quarters since. The position peaked at $545 in Q4 2025. 1,096 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Elevated Capital Advisors held 4 shares of Xylem worth $473 as of Q2 2026.
  • Elevated Capital Advisors left its Xylem share count unchanged in Q2 2026.
  • Xylem made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #800 holding.
  • Elevated Capital Advisors first reported a position in Xylem in Q4 2025 and has held it in 3 quarters since.
  • Elevated Capital Advisors's Xylem position peaked at $545 in Q4 2025.
  • 1,096 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.